Results 11 to 20 of about 169,585 (295)

The diagnostic dilemma in a patient with neuroleptic malignant syndrome during the COVID‐19 pandemic: A significant increase in acute phase reactants

open access: yesClinical Case Reports, 2023
Key Clinical Message In some patients, neuroleptic malignant syndrome is accompanied significant high levels of erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP).
Forouzan Elyasi   +5 more
doaj   +1 more source

Antipsychotic Response in the First Week Predicts Later Efficacy [PDF]

open access: yes, 2012
Background and Aims: Time of onset of antipsychotic action is still a debated matter. We aimed to replicate and extend previous findings that early response can predict subsequent non-response.
Andrisano, Costanza   +7 more
core   +1 more source

Adjunctive antidepressive pharmacotherapy in schizophrenia patients

open access: yesEuropean Psychiatry, 2021
Depressive symptoms during long-term course of schizophrenia constitute an important and frequent clinical problem. They may occur either as stand-alone major depressive episodes (MDEs) or as part of the schizophrenic negative syndrome.
M. Zink
doaj   +1 more source

Comparison of droperidol and haloperidol for acute agitation in the emergency department: A retrospective cohort study [PDF]

open access: yesMental Health Clinician
Introduction To compare the effectiveness of droperidol and haloperidol for acute agitation in the emergency department. Methods Data from electronic health records were collected from January 1, 2022, to August 25, 2023, across 6 emergency departments ...
Francesca DiGuglielmo, PharmD   +4 more
doaj   +1 more source

Challenges in schizoaffetive disorder therapeutic – a case report of a patient with hiperprolactinemia

open access: yesEuropean Psychiatry, 2021
Introduction The only FDA approval therapeutic for schizoaffective disorder is paliperidone. Hiperprolactinemia is one of the most frequent side effects induced by first generation antipsychotics (FGA) or by second generation antipsychotic (SGA), such ...
D. Rodrigues   +3 more
doaj   +1 more source

Antipsychotics for irritability in children with Autism Spectrum Disorders

open access: yesEuropean Psychiatry, 2022
Introduction Autism is a neurodevelopmental disorder characterized by qualitative impairments in social interaction, communication, and restricted and repetitive behaviors [1]. Despite of these symptoms, some patients present different manifestations of
V. Muñoz Martinez   +2 more
doaj   +1 more source

Haloperidol and Ziprasidone for Treatment of Delirium in Critical Illness [PDF]

open access: yes, 2018
BACKGROUND: There are conflicting data on the effects of antipsychotic medications on delirium in patients in the intensive care unit (ICU). METHODS: In a randomized, double-blind, placebo-controlled trial, we assigned patients with acute ...
Bernard, G.R.   +31 more
core   +1 more source

Dosage of antipsychotics in China routine practice

open access: yesEuropean Psychiatry, 2021
Introduction The antipsychotic dosage of Chinese schizophrenia patients has rarely been studied, although nonstandard dosage has impact on prognosis. Objectives To describe the dosage of antipsychotics in China routine practice.
T. Zhang, R. Chi, T. Wu, Y. Xu, W. Dong
doaj   +1 more source

Tobacco dependence and schizophrenia: Tunisian cross-sectional study of 50 cases

open access: yesEuropean Psychiatry, 2022
Introduction Tobacco-use is currently one of the major public health problems and is more common among patients with schizophrenia. Objectives We aimed in this study to estimate the prevalence of smoking in a population of patients with schizophrenia ...
M. Jabeur   +5 more
doaj   +1 more source

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study. [PDF]

open access: yes, 2017
ObjectiveParkinson's disease psychosis (PDP) is a frequent complication of idiopathic Parkinson's disease (iPD) with significant impact on quality of life and association with poorer outcomes.
Bizzarri   +29 more
core   +2 more sources

Home - About - Disclaimer - Privacy